.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Johnson and Johnson
Argus Health
Fuji
Federal Trade Commission
Medtronic
Covington
Mallinckrodt
Harvard Business School
Express Scripts

Generated: July 28, 2017

DrugPatentWatch Database Preview

TOBRADEX Drug Profile

« Back to Dashboard

Which patents cover Tobradex, and what generic Tobradex alternatives are available?

Tobradex is a drug marketed by Novartis Pharms Corp and is included in three NDAs. There are three patents protecting this drug.

The generic ingredient in TOBRADEX is dexamethasone; tobramycin. There are thirty-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dexamethasone; tobramycin profile page.

Summary for Tradename: TOBRADEX

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list43
Clinical Trials: see list15
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TOBRADEX at DailyMed

Pharmacology for Tradename: TOBRADEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
TOBRADEX
dexamethasone; tobramycin
OINTMENT;OPHTHALMIC050616-001Sep 28, 1988RXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TOBRADEX
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050592-001Aug 18, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TOBRADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
TOBRADEX
dexamethasone; tobramycin
OINTMENT;OPHTHALMIC050616-001Sep 28, 1988► Subscribe► Subscribe
Novartis Pharms Corp
TOBRADEX
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050592-001Aug 18, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Covington
US Army
Deloitte
McKesson
Chinese Patent Office
Daiichi Sankyo
Baxter
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot